HCA
AURA icon

Harbor Capital Advisors’s Aura Biosciences AURA Stock Holding History

Harbor Capital Advisors’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-32,977
Closed -$180K – 1240
2025
Q4 		$180K Buy
32,977
+6,481
+24% +$38.5K 0.01% 626
2025
Q3 		$164K Sell
26,496
-6,243
-19% -$40.8K 0.01% 615
2025
Q2 		$205K Buy
32,739
+6,998
+27% +$40.9K 0.01% 604
2025
Q1 		$151K Buy
+25,741
New +$195K 0.01% 631

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Harbor Capital Advisors's AURA Position: Q1 2026 in Review

Harbor Capital Advisors sold out of Aura Biosciences (AURA) in Q1 2026, closing a stake of 32,977 shares — an estimated $180K sold.

Harbor Capital Advisors first reported a position in AURA in Q1 2025 and held it in 4 quarters. The position peaked at $205K in Q2 2025. 126 funds tracked by Wall St. Rank hold AURA as of Q1 2026.

  • Harbor Capital Advisors reported no remaining Aura Biosciences position as of Q1 2026 after selling out during the quarter.
  • Harbor Capital Advisors sold 32,977 Aura Biosciences shares in Q1 2026, an estimated $180K.
  • Harbor Capital Advisors first reported a position in Aura Biosciences in Q1 2025 and held it in 4 quarters.
  • Harbor Capital Advisors's Aura Biosciences position peaked at $205K in Q2 2025.
  • 126 funds tracked by Wall St. Rank held Aura Biosciences as of Q1 2026.

Based on Harbor Capital Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.